Zhiming Xu Selected Research

Zhiming Xu Research Topics

Disease

6	Neoplasms (Cancer) 12/2023 - 01/2014
4	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2022 - 01/2017
3	Inflammation (Inflammations) 04/2024 - 08/2022
2	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2018
2	Pituitary Neoplasms (Pituitary Adenoma) 12/2017 - 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 12/2023
1	Necrosis 12/2023
1	Trigeminal Neuralgia (Tic Douloureux) 10/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Osteoarthritis 01/2023
1	Ischemic Stroke 01/2023
1	Stroke (Strokes) 01/2023
1	Infections 12/2022
1	Carcinogenesis 08/2022
1	Pain (Aches) 02/2022
1	Neuroinflammatory Diseases 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	COVID-19 10/2021
1	Femoral Fractures (Femoral Fracture) 05/2021
1	Bone Fractures (Bone Fracture) 05/2021
1	Infertility (Sterility) 01/2021
1	Aneurysm (Aneurysms) 01/2021
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021
1	Tuberculosis (Tuberculoses) 01/2021
1	Kidney Diseases (Kidney Disease) 03/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2020
1	Reperfusion Injury 01/2020
1	Brain Ischemia (Cerebral Ischemia) 01/2020
1	Ischemia 01/2020
1	Embolic Stroke 12/2019
1	Choristoma (Ectopic Tissue) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 12/2018
1	Cerebral Infarction 12/2018
1	Osteosarcoma (Osteogenic Sarcoma) 01/2018
1	Neuroblastoma 01/2017
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2014
1	Carcinoma (Carcinomatosis) 01/2014
1	Vascular System Injuries 01/2014
1	Melanoma (Melanoma, Malignant) 05/2012

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 04/2024 - 08/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023 - 01/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2014
2	CytokinesIBA 04/2024 - 12/2018
2	AntioxidantsIBA 12/2023 - 01/2020
2	Interleukin-6 (Interleukin 6)IBA 12/2023 - 12/2014
2	CateninsIBA 01/2020 - 12/2018
2	Cadherins (E-Cadherin)IBA 01/2019 - 12/2018
1	Pyrin Domain-Containing 3 Protein NLR FamilyIBA 04/2024
1	NF-kappa B (NF-kB)IBA 12/2023
1	catalpolIBA 12/2023
1	IridoidsIBA 12/2023
1	Caspase 9IBA 12/2023
1	InterleukinsIBA 12/2023
1	Caspase 3 (Caspase-3)IBA 12/2023
1	beta CateninIBA 01/2023
1	AlbuminsIBA 12/2022
1	Blood Glucose (Blood Sugar)IBA 12/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2022
1	ACT001IBA 01/2022
1	Factor VII (Proconvertin)IBA 01/2022
1	cyasteroneIBA 05/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2021
1	Nonesterified Fatty Acids (NEFA)IBA 01/2021
1	Isoniazid (Ftivazide)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 03/2020
1	Neuroprotective AgentsIBA 01/2020
1	triptolideIBA 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	Liposomes (Liposome)IBA 01/2020
1	artenimol (dihydroartemisinin)IBA 01/2020
1	Transferrin (beta 2 Transferrin)IBA 01/2020
1	Buthionine SulfoximineIBA 01/2020
1	Tissue Plasminogen Activator (Alteplase)FDA Link 12/2019
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2018
1	TankyrasesIBA 12/2018
1	Interleukin-18 (Interleukin 18)IBA 12/2018
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2017
1	sesaminIBA 01/2017
1	Hormones (Hormone)IBA 12/2014
1	ferric oxide (iron oxide)IBA 01/2014
1	PolyethyleneimineIBA 01/2014
1	erucylphosphocholineIBA 01/2014
1	RutheniumIBA 05/2012
1	ZincIBA 05/2012
1	PorphyrinsIBA 05/2012
1	CopperIBA 05/2012
1	NickelIBA 05/2012
1	TungstenIBA 05/2012

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2014
1	Time-to-Treatment 01/2023
1	Thrombectomy 01/2023
1	Electrodes (Electrode) 12/2022
1	Deep Brain Stimulation 12/2022
1	Personal Protective Equipment 10/2021
1	Cardiac Rehabilitation 10/2021
1	Secondary Prevention 10/2021
1	Precision Medicine 01/2020
1	Synchrotrons 12/2019